Study Of OX40 Agonist PF-04518600 Alone And In Combination With 4-1BB Agonist PF-05082566
Clinical trial NCT02315066 · COMPLETED
Trial details
- NCT number
- NCT02315066
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-23
- Primary completion
- 2020-11-12
- Enrollment
- 174
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.